These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Herpes simplex virus type 1 is the prevailing cause of genital herpes in the Tel Aviv area, Israel. Samra Z, Scherf E, Dan M. Sex Transm Dis; 2003 Oct; 30(10):794-6. PubMed ID: 14520180 [Abstract] [Full Text] [Related]
3. A seroprevalence study of herpes virus type 2 infection in Israeli women: implications for routine screening. Isacsohn M, Bar On E, Yaeger Y, Smetana Z, Weiner D, Slater PE. Isr J Med Sci; 1994 Oct; 30(5-6):379-83. PubMed ID: 8034487 [Abstract] [Full Text] [Related]
6. Virological, serological and epidemiological study of 255 consecutive cases of genital herpes in a sexually transmitted disease clinic of Paris (France): a prospective study. Janier M, Scieux C, Méouchi R, Tournoux C, Porcher R, Maillard A, Fouéré S, Taquin Y, Lassau F, Morel P. Int J STD AIDS; 2006 Jan; 17(1):44-9. PubMed ID: 16409679 [Abstract] [Full Text] [Related]
7. Importance of herpes simplex virus type-1 (HSV-1) in primary genital herpes. Nieuwenhuis RF, van Doornum GJ, Mulder PG, Neumann HA, van der Meijden WI. Acta Derm Venereol; 2006 Jan; 86(2):129-34. PubMed ID: 16648915 [Abstract] [Full Text] [Related]
8. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Roberts CM, Pfister JR, Spear SJ. Sex Transm Dis; 2003 Oct; 30(10):797-800. PubMed ID: 14520181 [Abstract] [Full Text] [Related]
9. [Herpes simplex virus type 1 and 2 in Switzerland]. Laubereau B, Zwahlen M, Neuenschwander B, Heininger U, Schaad UB, Desgrandchamps D. Schweiz Med Wochenschr; 2000 Feb 05; 130(5):143-50. PubMed ID: 10701231 [Abstract] [Full Text] [Related]
10. The changing epidemiology of HSV-1 and HSV-2 and implications for serological testing. Lafferty WE. Herpes; 2002 Jul 05; 9(2):51-5. PubMed ID: 12106513 [Abstract] [Full Text] [Related]
15. Decline in the prevalence of antibodies to herpes simplex virus types 1 and 2 among Israeli young adults between 1984 and 2002. Davidovici BB, Grotto I, Balicer RD, Robinson NJ, Cohen D. Sex Transm Dis; 2006 Nov 05; 33(11):641-5. PubMed ID: 16614586 [Abstract] [Full Text] [Related]
16. Incidence and prevalence of herpes simplex virus infections in adolescent women. Fife KH, Fortenberry JD, Ofner S, Katz BP, Morrow RA, Orr DP. Sex Transm Dis; 2006 Jul 05; 33(7):441-4. PubMed ID: 16540882 [Abstract] [Full Text] [Related]
17. Seroprevalence of herpes simplex virus 1 and 2 and correlates of infection in Israel. Davidovici BB, Green M, Marouni MJ, Bassal R, Pimenta JM, Cohen D. J Infect; 2006 May 05; 52(5):367-73. PubMed ID: 16213591 [Abstract] [Full Text] [Related]
18. A prospective study of new infections with herpes simplex virus type 1 and type 2. Chiron HSV Vaccine Study Group. Langenberg AG, Corey L, Ashley RL, Leong WP, Straus SE. N Engl J Med; 1999 Nov 04; 341(19):1432-8. PubMed ID: 10547406 [Abstract] [Full Text] [Related]